Quick Answer
iSpecimen Inc. reported Earnings Per Share Diluted of $17.58 (loss) per share for the year ending 2024.
- iSpecimen Inc. showed an increase of +28.4% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from iSpecimen Inc.'s annual report (Form 10-K), filed with the SEC on April 14, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $4.23 (loss) per share | Q2 2021: $0.87 (loss) per share | Q3 2021: $0.22 (loss) per share | Q1 2022: $0.27 (loss) per share | Q2 2022: $0.30 (loss) per share | Q3 2022: $0.35 (loss) per share | Q1 2023: $0.27 (loss) per share | Q2 2023: $0.39 (loss) per share | Q3 2023: $4.66 (loss) per share | Q1 2024: $6.36 (loss) per share | Q2 2024: $3.72 (loss) per share | Q3 2024: $2.10 (loss) per share | Q1 2025: $0.71 (loss) per share | Q2 2025: $0.42 (loss) per share | Q3 2025: $0.48 (loss) per share.
- Over the full 5 years of available data (2020 to 2024), iSpecimen Inc.'s Earnings Per Share Diluted has declined by 253.7%.
- Historical annual values: Fiscal year 2024: $17.58 (loss) per share | Fiscal year 2023: $24.55 (loss) per share | Fiscal year 2022: $1.16 (loss) per share | Fiscal year 2021: $2.09 (loss) per share | Fiscal year 2020: $4.97 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: